Post-approval studies (Phase 4)Study completedNCT06922643
What this trial is testing
Study of the Efficacy and Safety of Pegnano Plus Barivir (Ribavirin) in Treatment-naïve Patients With Chronic Hepatitis C at KienGiang General Hospital
Who this might be right for
Chronic Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 100